abstract |
The invention provides tetrahydroquinoline and related compounds, pharmaceutical compositions, methods of inhibiting RORĪ³ activity, reducing the amount of IL-17 in a subject, and treating immune disorders and inflammatory disorders using such tetrahydroquinoline and related compounds are provided. |